Monoclonal Antibody and an Antibody-toxin Conjugate to a Cell Surface Proteoglycan of Melanoma Cells Suppress in Vivo Tumor Growth

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1983 Jan 1

PMID 6572905

Citations 27

Authors

T F Bumol

Q C Wang

R A Reisfeld

N O Kaplan

Affiliations

Soon will be listed here.

Abstract

A monoclonal antibody directed against a cell surface chondroitin sulfate proteoglycan of human melanoma cells, 9.2.27, and its diphtheria toxin A chain (DTA) conjugate were investigated for their effects on in vitro protein synthesis and in vivo tumor growth of human melanoma cells. The 9.2.27 IgG and its DTA conjugate display similar serological activities against melanoma target cells but only the conjugate can induce consistent in vitro inhibition of protein synthesis and toxicity in M21 melanoma cells. However, both 9.2.27 IgG and its DTA conjugate effect significant suppression of M21 tumor growth in vivo in an immunotherapy model of a rapidly growing tumor in athymic nu/nu mice, suggesting that other host mechanisms may mediate monoclonal antibody-induced tumor suppression.

Citing Articles

A chondroitin sulfate proteoglycan 4‑specific monoclonal antibody inhibits melanoma cell invasion in a spheroid model.

Uranowska K, Samadaei M, Kalic T, Pinter M, Breiteneder H, Hafner C Int J Oncol. 2021; 59(3).

PMID: 34318902 PMC: 8357264. DOI: 10.3892/ijo.2021.5250.

The Properties of Cysteine-Conjugated Antibody-Drug Conjugates Are Impacted by the IgG Subclass.

Datta-Mannan A, Choi H, Stokell D, Tang J, Murphy A, Wrobleski A AAPS J. 2018; 20(6):103.

PMID: 30255287 DOI: 10.1208/s12248-018-0263-0.

Bacterial Toxins for Cancer Therapy.

Zahaf N, Schmidt G Toxins (Basel). 2017; 9(8).

PMID: 28788054 PMC: 5577570. DOI: 10.3390/toxins9080236.

Theranostic impact of NG2/CSPG4 proteoglycan in cancer.

Nicolosi P, Dallatomasina A, Perris R Theranostics. 2015; 5(5):530-44.

PMID: 25767619 PMC: 4350014. DOI: 10.7150/thno.10824.

Recombinant DNA technology for melanoma immunotherapy: anti-Id DNA vaccines targeting high molecular weight melanoma-associated antigen.

Barucca A, Capitani M, Cesca M, Tomassoni D, Kazmi U, Concetti F Mol Biotechnol. 2014; 56(11):1032-9.

PMID: 25027754 DOI: 10.1007/s12033-014-9782-9.

References

Honjo T, NISHIZUKA Y, HAYAISHI O . Diphtheria toxin-dependent adenosine diphosphate ribosylation of aminoacyl transferase II and inhibition of protein synthesis. J Biol Chem. 1968; 243(12):3553-5. View

Stuchbury T, Shipton M, Norris R, Malthouse J, Brocklehurst K, Herbert J . A reporter group delivery system with both absolute and selective specificity for thiol groups and an improved fluorescent probe containing the 7-nitrobenzo-2-oxa-1,3-diazole moiety. Biochem J. 1975; 151(2):417-32. PMC: 1172373. DOI: 10.1042/bj1510417. View

Chee D, Boddie A, Roth J, Holmes E, Morton D . Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium. Cancer Res. 1976; 36(4):1503-9. View

Comper W, Laurent T . Physiological function of connective tissue polysaccharides. Physiol Rev. 1978; 58(1):255-315. DOI: 10.1152/physrev.1978.58.1.255. View

Lindahl U, Hook M . Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem. 1978; 47:385-417. DOI: 10.1146/annurev.bi.47.070178.002125. View

KOPROWSKI H, Steplewski Z, Herlyn D, Herlyn M . Study of antibodies against human melanoma produced by somatic cell hybrids. Proc Natl Acad Sci U S A. 1978; 75(7):3405-9. PMC: 392785. DOI: 10.1073/pnas.75.7.3405. View

Ey P, Prowse S, JENKIN C . Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry. 1978; 15(7):429-36. DOI: 10.1016/0161-5890(78)90070-6. View

Bernstein I, Tam M, Nowinski R . Mouse leukemia: therapy with monoclonal antibodies against a thymus differentiation antigen. Science. 1980; 207(4426):68-71. DOI: 10.1126/science.6965328. View

Ross W, Thorpe P, Cumber A, EDWARDS D, Hinson C, Davies A . Increased toxicity of diphtheria toxin for human lymphoblastoid cells following covalent linkage to anti-(human lymphocyte) globulin or its F(ab')2 fragment. Eur J Biochem. 1980; 104(2):381-90. DOI: 10.1111/j.1432-1033.1980.tb04438.x. View

10.

Woodbury R, Brown J, Yeh M, Hellstrom I, Hellstrom K . Identification of a cell surface protein, p97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci U S A. 1980; 77(4):2183-7. PMC: 348676. DOI: 10.1073/pnas.77.4.2183. View

11.

Krolick K, Villemez C, Isakson P, UHR J, Vitetta E . Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin. Proc Natl Acad Sci U S A. 1980; 77(9):5419-23. PMC: 350070. DOI: 10.1073/pnas.77.9.5419. View

12.

Giuliani F, Kaplan N . New doxorubicin analogs active against doxorubicin-resistant colon tumor xenografts in the nude mouse. Cancer Res. 1980; 40(12):4682-7. View

13.

Proia R, Wray S, Hart D, Eidels L . Characterization and affinity labeling of the cationic phosphate-binding (nucleotide-binding) peptide located in the receptor-binding region of the B-fragment of diphtheria toxin. J Biol Chem. 1980; 255(24):12025-33. View

14.

Herlyn D, Steplewski Z, Herlyn M, KOPROWSKI H . Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Cancer Res. 1980; 40(3):717-21. View

15.

Mitchell K, Fuhrer J, Steplewski Z, KOPROWSKI H . Biochemical characterization of human melanoma cell surfaces: dissection with monoclonal antibodies. Proc Natl Acad Sci U S A. 1980; 77(12):7287-91. PMC: 350487. DOI: 10.1073/pnas.77.12.7287. View

16.

Ritz J, Pesando J, Sallan S, Clavell L, Rosenthal P, Schlossman S . Serotherapy of acute lymphoblastic leukemia with monoclonal antibody. Blood. 1981; 58(1):141-52. View

17.

Miller R, Maloney D, McKillop J, Levy R . In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia. Blood. 1981; 58(1):78-86. View

18.

Miller R, Levy R . Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody. Lancet. 1981; 2(8240):226-30. DOI: 10.1016/s0140-6736(81)90475-x. View

19.

Trowbridge I, Domingo D . Anti-transferrin receptor monoclonal antibody and toxin-antibody conjugates affect growth of human tumour cells. Nature. 1981; 294(5837):171-3. DOI: 10.1038/294171a0. View

20.

Scheinberg D, Strand M . Leukemic cell targeting and therapy by monoclonal antibody in a mouse model system. Cancer Res. 1982; 42(1):44-9. View